RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

ELEVATUS WELATH MANAGEMENT's Holding History (CIK: 0001982776)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024

Shares 342,567 Value ($000) $2,569 Avg Close $8.72 Range $6.75 - $10.66

Q1 2024

Shares 29,650 Value ($000) $296 Avg Close $11.14 Range $8.68 - $15.74

Q4 2023

Shares 24,650 Value ($000) $243 Avg Close $7.13 Range $4.97 - $11.17

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2024	342,567	$2,569	$8.72	$6.75 - $10.66
Q1 2024	29,650	$296	$11.14	$8.68 - $15.74
Q4 2023	24,650	$243	$7.13	$4.97 - $11.17